Steve C Chen, P , PharmD, F , FASHP, F , FCSHP, F , FNAP UBP C Co-Chair, R , Right C Care In Initiative; A ; Associate D Dean f for C Clinical A Affairs; W ; William A A. a . and Josephine A A. . He Heeres Chair i in C Community P Pharmacy; A ; Associate P Professor o of C Clinical Pharmacy, U , University o of S Southern C California In addition to his roles as professor and dean, Dr. Chen is part of a team of USC faculty directing $12 million grant-funded research, evaluating the impact of pharmacist-managed patient care services for underserved populations. Dr. Chen actively partners with the state of CA Department of Public Health in evolving the state laws and regulations on the practice of pharmacy. His current clinical practice role includes the supervision of clinical and consultative pharmacy services to 19 safety net community clinics in Southern California. At these clinics, Dr. Chen oversees teams of clinical pharmacists, pharmacy residents, pharmacy students and pharmacy techs. Prior to joining the USC faculty in 1998, Dr. Chen provided administrative and clinical services to Cedars-Sinai Medical Group (CSMG) in Beverly Hills and served as a Faculty-in- Residence at Cedars Sinai Medical Center. From 1994-1998, Dr. Chen served as Clinical and Residency Coordinator at the VA Outpatient Clinic in Los Angeles. Prior to that, he helped develop the Ambulatory Care and Education Program at Sepulveda VA Medical Center also in Los Angeles. Dr. Chen's responsibilities include the provision of disease management and consultative services and coordination of clerkship students at several safety net clinics. Pharmacist-run disease management services provided include asthma, dyslipidemia, diabetes, hypertension, and heart failure. His lecture topics for the School of Pharmacy and postgraduate education include asthma/chronic obstructive pulmonary disease, arthritis, dyslipidemia, and other cardiovascular diseases. Chen received an honorary fellowship of the California Society of Health- System Pharmacists in 2000 and an honorary fellowship of the American Society of Health-System Pharmacists (ASHP) in 2001. He received the Best Practices Award from ASHP in 2002, and has NABP certification in dyslipidemia and asthma management. Dr. Chen has received 7 teaching awards from USC students and residents. In 2013, Dr. Chen was awarded the American Pharmacists Association Foundation Pinnacle Award for Individual Achievement. 1
Margolis KL, Asche SE, Bergdall AR, et al. Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Control: A Cluster Randomized Clinical Trial. JAMA. 2013;310(1):46–56. doi:10.1001/jama.2013.6549 2
Magid DJ, Green BB. Home blood pressure monitoring: take it to the bank. JAMA : the journal of the American Medical Association . 310(1):40-41. doi:10.1001/jama.2013.6550 3
JAMA Network Open. 2018;1(5):e181617. doi:10.1001/jamanetworkopen.2018.1617 4
Cedars-Sinai Barbershop Project Outcome Intervention Control Group (N=132) Group (N=171) Systolic Blood Pressure- mmHg Baseline 152.8 +/- 10.3 154.6 +/- 12.0 6 months 125.8 +/- 11.0 145.4 +/- 15.2 Hypertension Control at 6 mos.- no. (%) BP < 140/90 mmHg 118 (89.4) 55 (32.2) BP < 135/85 mmHg 109 (82.6) 32 (18.7) BP < 130/80 mmHg 84 (63.6) 20 (11.7) Mean no. of blood pressure medications 2.6 +/- 0.9 1.4 +/- 1.4 per participant Drug Class- no. (%) ACEi or ARB 130 (98.5) 71 (41.5) Calcium channel blocker 125 (94.7) 56 (32.7) Diuretic 61 (46.2) 49 (28.7) Aldosterone antagonist 14 (10.6) 2 (1.2) Beta-blocker 33 (19.3) 14 (10.6) N Engl J Med 2018; 378:1291-1301
http://calrightmeds.org/ 6
Recommend
More recommend
